ArticleScientific reports2014

Antitumor effects and molecular mechanisms of figitumumab, a humanized monoclonal antibody to IGF-1 receptor, in esophageal carcinoma.

Tiehong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.